FRI-314 Plasminogen activator inhibitor-1 (PAI-1) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease

FRI-314 Plasminogen activator inhibitor-1 (PAI-1) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 80; pp. S501 - S502
Main Authors: Rosso, Chiara, Guariglia, Marta, Armandi, Angelo, Caviglia, Gian Paolo, Dileo, Eleonora, Saba, Francesca, Castelnuovo, Gabriele, Scalici, Marilu’ Benedetta, del Campo, Nuria Pérez Diaz, Gjini, Kamela, Abate, Maria Lorena, Olivero, Antonella, Parasiliti-Caprino, Mirko, Bo, Simona, Bugianesi, Elisabetta
Format: Journal Article
Language:English
Published: Elsevier B.V 01-06-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(24)01525-3